FATE

NASDAQStock$1.32-0.01 (-0.38%)
Mkt Cap 154.0MP/E Div Yield Beta 2.23Vol 942.3K
52W$0.92
$1.67

ETFs That Hold FATE (Fate Therapeutics, Inc.)

1M

+17.26%

3M

+1.15%

6M

-1.12%

YTD

+34.33%

1Y

+6.00%

3Y

-78.17%

5Y

-98.56%

ETFs That Hold FATE

Fate Therapeutics, Inc. is held by 32 ETFs. The largest position by market value is in VTI (Vanguard Total Stock Market ETF).

ETFFund NameWeight
VTIVanguard Total Stock Market ETF0.00%
IWMiShares Russell 2000 ETF0.00%
VXFVanguard Extended Market ETF0.00%
IWNiShares Russell 2000 Value ETF0.01%
CNCRLoncar Cancer Immunotherapy ETF3.33%
SCHASchwab U.S. Small-Cap ETF0.00%
VTWOVanguard Russell 2000 ETF0.00%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.01%
VHTVanguard Health Care ETF0.00%
IWCiShares Micro-Cap ETF0.03%
DFATDimensional - US Targeted Value ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
VTWVVanguard Russell 2000 Value ETF0.01%
RSSLGlobal X - Russell 2000 ETF0.01%
QQQSInvesco NASDAQ Future Gen 200 ETF0.42%
SMMDiShares Russell 2500 ETF0.00%
JHMHJohn Hancock Multifactor Health Care ETF0.10%
IWViShares Russell 3000 ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
STSBiShares Factors US Small Blend Style ETF0.19%

Excludes leveraged and inverse ETFs.

Page 1 of 2Next

Frequently Asked Questions

How many ETFs hold FATE?
Fate Therapeutics, Inc. (FATE) is held by 32 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VTI (Vanguard Total Stock Market ETF).
What is the largest ETF that holds FATE?
By fund size, VTI (Vanguard Total Stock Market ETF) with $2.00T in AUM holds 0.00% of its portfolio in FATE, representing $3.5M in market value.
What percentage of CNCR is FATE?
FATE makes up 3.33% of CNCR (Loncar Cancer Immunotherapy ETF), making it one of the largest positions in that fund.
Is FATE in the S&P 500?
FATE is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.